71c4
"as you would know milling is not only cost of production, "
Not sure what your point is? I never said it was. You talk about pre strip being done, but the scoping study talks about cost of production for LIFE of mine not just initial production.
Further, my concern has nothing to do with getting the ore out of the ground (that should be relatively simple), but rather with the extraction of the gold from the ore, ie its processing (the refractory ore that is, not the oxides which should be easy enough).
My concern therefore is if the ore is indeed refractory then imo the cost of production as per scoping study is very optimistic even with copper credits.
And talking about the copper...copper can cause even further issues for production for gold mines (again depends on geology). Take a look at KGL's Gabanintha/Burnakura project (which they hope to restart in 2012). That mine actually STOPPED production due to the copper 'contamination' causing issues for gold production....on the other hand, there are copper/gold projeects where its not an issue and therefore copper becomes a valuable byproduct (again using KGL as an example, their Andash project in Kyrgyzstand the copper is extremely important for profitability - assumign the project ever gets going that is). I have no idea which will be the case for Deflector...again need to wait for very detailed (and hopefully non-sugar coated) metallurgy results.
I am more than happy to be proven wrong by future metallurgical results and/or DFS as I have been looking hard the last few weeks for junior goldies that provides good value and am struggling since they all seem to be inflated. Have only identified one that I've invested in and still looking for others - MYG fits the bill IF they can prove to me their scoping study results are credible.
Cdchi1
- Forums
- ASX - By Stock
- MYG
- why doesn't the market take to myg
why doesn't the market take to myg, page-54
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYG (ASX) to my watchlist
|
|||||
Last
77.5¢ |
Change
0.055(7.64%) |
Mkt cap ! $70.88M |
Open | High | Low | Value | Volume |
73.0¢ | 77.5¢ | 73.0¢ | $8.145K | 10.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6500 | 78.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.0¢ | 5567 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6500 | 0.785 |
2 | 9148 | 0.775 |
2 | 8951 | 0.735 |
1 | 1296 | 0.730 |
1 | 10000 | 0.725 |
Price($) | Vol. | No. |
---|---|---|
0.790 | 5567 | 1 |
0.800 | 6061 | 1 |
0.850 | 15567 | 1 |
0.900 | 9 | 1 |
0.980 | 2520 | 1 |
Last trade - 13.46pm 15/07/2024 (20 minute delay) ? |
Featured News
MYG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online